UTI Prophylaxis Recommendations
For recurrent urinary tract infections (rUTIs), continuous or postcoital antimicrobial prophylaxis is strongly recommended when non-antimicrobial interventions have failed, with trimethoprim-sulfamethoxazole, nitrofurantoin, and methenamine hippurate being the most effective options. 1
Definition and Impact of Recurrent UTIs
- Recurrent UTIs are defined as at least three UTIs per year or two UTIs in the last 6 months 1
- rUTIs significantly impact quality of life, affecting social and sexual relationships, self-esteem, and work capacity 1
First-Line Non-Antimicrobial Prophylaxis Options
Before initiating antimicrobial prophylaxis, consider these non-antimicrobial interventions:
Increased Fluid Intake
Vaginal Estrogen for Postmenopausal Women
Methenamine Hippurate
Cranberry Products
Probiotics
Antimicrobial Prophylaxis Regimens
When non-antimicrobial interventions fail, antimicrobial prophylaxis should be considered:
Continuous Daily Prophylaxis Options:
Nitrofurantoin:
Trimethoprim-Sulfamethoxazole (TMP-SMX):
Trimethoprim alone:
Postcoital Prophylaxis Options:
- TMP-SMX: 40mg/200mg or 80mg/400mg single dose after intercourse 1
- Nitrofurantoin: 50mg or 100mg single dose after intercourse 1
Intermittent Prophylaxis:
- Fosfomycin: 3g every 10 days 1
Duration of Prophylaxis
- Typical duration ranges from 6 to 12 months 1, 3
- Clinical practice may vary from 3-6 months to 1 year with periodic monitoring 1
- Prophylaxis effect typically lasts only during active treatment period 1, 3
- After discontinuation, infection rates often return to pre-prophylaxis levels 3, 4
Important Considerations and Monitoring
- Obtain urine culture before initiating prophylaxis to confirm diagnosis 1
- Do not perform routine surveillance cultures in asymptomatic patients 1
- Do not treat asymptomatic bacteriuria 1
- Discuss potential adverse effects of antimicrobials with patients 1
- For nitrofurantoin, monitor for rare but serious pulmonary (0.001%) and hepatic toxicity (0.0003%) 1
- Consider emergence of resistant organisms, particularly non-E. coli infections after prophylaxis discontinuation 3